Last Price
3.55
Today's Change
-0.20 (5.33%)
Day's Change
3.47 - 3.79
Trading Volume
688,793
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Keith Michael Gottesdiener M.D., Ph.D. Dr. Keith Michael Gottesdiener M.D., Ph.D.
Full Time Employees: 234 234
IPO Date: 2022-10-20 2022-10-20
CIK: 0001894562 0001894562
ISIN: US74168J1016 US74168J1016
CUSIP: 74168J101 74168J101
Beta: 1.88 1.88
Last Dividend: 0.00 0.00
Dcf Diff: 3.24 3.24
Dcf: 0.31 0.31
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.